(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 15.98% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.45%.
Cvrx's revenue in 2026 is $61,188,000.On average, 9 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,775,582,515, with the lowest CVRX revenue forecast at $1,681,404,470, and the highest CVRX revenue forecast at $1,851,031,518. On average, 9 Wall Street analysts forecast CVRX's revenue for 2027 to be $2,068,320,383, with the lowest CVRX revenue forecast at $1,905,939,849, and the highest CVRX revenue forecast at $2,265,867,825.
In 2028, CVRX is forecast to generate $2,598,141,823 in revenue, with the lowest revenue forecast at $2,245,353,795 and the highest revenue forecast at $2,920,451,863.